{"id":"placebo-100-for-aspirin-100","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo, this formulation contains no active pharmaceutical ingredient and serves as a control arm in Phase 3 clinical trials. It is designed to be indistinguishable from the active Aspirin 100 mg comparator to maintain blinding and assess the true efficacy of aspirin through comparison against inert treatment.","oneSentence":"This is a placebo control formulation used in clinical trials to compare against Aspirin 100 mg.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:26.483Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials comparing Aspirin 100 mg efficacy"}]},"trialDetails":[{"nctId":"NCT07205250","phase":"EARLY_PHASE1","title":"Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2026-02-20","conditions":"Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm","enrollment":224},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT07113158","phase":"PHASE3","title":"Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Sudden Sensorineural Hearing Loss","enrollment":142},{"nctId":"NCT05310968","phase":"PHASE4","title":"Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-11-12","conditions":"Branch Atheromatous Disease","enrollment":970},{"nctId":"NCT05604638","phase":"PHASE3","title":"Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangxi Medical University","startDate":"2024-04-24","conditions":"Acute Ischemic Stroke","enrollment":348},{"nctId":"NCT07290751","phase":"PHASE4","title":"Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-11","conditions":"Acute Ischemic Stroke","enrollment":976},{"nctId":"NCT07275749","phase":"PHASE3","title":"Acetyl-leucine in Post-stroke Ataxia","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT06774846","phase":"PHASE3","title":"Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-02","conditions":"Acute Pneumonia, Elderly Person","enrollment":600},{"nctId":"NCT05380063","phase":"PHASE4","title":"Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-02-14","conditions":"Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy","enrollment":2300},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT06014060","phase":"NA","title":"24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-06-20","conditions":"Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent","enrollment":3300},{"nctId":"NCT02813824","phase":"PHASE3","title":"Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-11-14","conditions":"Lynch Syndrome","enrollment":852},{"nctId":"NCT02467582","phase":"PHASE3","title":"Adjuvant Aspirin Treatment for Colon Cancer Patients","status":"TERMINATED","sponsor":"Swiss Cancer Institute","startDate":"2016-06-09","conditions":"Colon Cancer","enrollment":1040},{"nctId":"NCT03047837","phase":"PHASE2","title":"A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients","status":"TERMINATED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2017-03-15","conditions":"Tertiary Prevention in Colon Cancer","enrollment":160},{"nctId":"NCT04214990","phase":"PHASE3","title":"Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients","status":"RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2020-02-15","conditions":"Aspirin, Gastric Cancer","enrollment":1700},{"nctId":"NCT03844191","phase":"PHASE1","title":"A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4","status":"COMPLETED","sponsor":"CeleCor Therapeutics","startDate":"2019-02-18","conditions":"Coronary Disease","enrollment":44},{"nctId":"NCT04145258","phase":"PHASE3","title":"Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis","status":"RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2021-02-07","conditions":"Tuberculous Meningitis","enrollment":768},{"nctId":"NCT03635749","phase":"PHASE3","title":"Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2018-09-17","conditions":"Acute Stroke, Transient Ischemic Attack","enrollment":6100},{"nctId":"NCT05531942","phase":"PHASE2, PHASE3","title":"Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2021-01-01","conditions":"Ischemic Stroke","enrollment":70},{"nctId":"NCT04448847","phase":"NA","title":"Mapping the MoA Behind GI Protection From Bif195","status":"COMPLETED","sponsor":"Chr Hansen","startDate":"2020-06-08","conditions":"Reduction of Small Intestinal Ulceration Risk","enrollment":25},{"nctId":"NCT05663307","phase":"PHASE2, PHASE3","title":"The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2021-01-01","conditions":"Ischemic Stroke, Acute","enrollment":80},{"nctId":"NCT01776424","phase":"PHASE3","title":"Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-02-28","conditions":"Prevention & Control","enrollment":27395},{"nctId":"NCT05568147","phase":"PHASE2, PHASE3","title":"Aspirin for Prophylaxis of TTP","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-10-01","conditions":"Thrombotic Thrombocytopenic Purpura","enrollment":100},{"nctId":"NCT04088513","phase":"PHASE4","title":"Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2020-01-22","conditions":"G6PD Deficiency, Stroke","enrollment":440},{"nctId":"NCT03558854","phase":"PHASE4","title":"Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2018-08-28","conditions":"Systemic Sclerosis","enrollment":70},{"nctId":"NCT04466670","phase":"PHASE2","title":"Hemostasis in COVID-19: an Adaptive Clinical Trial","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2020-07-11","conditions":"COVID-19","enrollment":379},{"nctId":"NCT04808895","phase":"PHASE3","title":"Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-04-01","conditions":"COVID-19, Thrombosis Pulmonary","enrollment":204},{"nctId":"NCT03279809","phase":"NA","title":"The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction","status":"TERMINATED","sponsor":"Woo Hyun Paik","startDate":"2017-10-12","conditions":"Biliary Stasis, Extrahepatic","enrollment":52},{"nctId":"NCT04407312","phase":"PHASE4","title":"Cilostazol and Endothelial Progenitor Cell","status":"UNKNOWN","sponsor":"Gyeongsang National University Hospital","startDate":"2016-01-01","conditions":"Myocardial Infarction, Acute","enrollment":60},{"nctId":"NCT02239120","phase":"PHASE3","title":"Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-11-27","conditions":"Stroke, Secondary Prevention","enrollment":5390},{"nctId":"NCT01998776","phase":"PHASE2, PHASE3","title":"Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2013-04","conditions":"Ulcer Hemorrhage","enrollment":82},{"nctId":"NCT01198379","phase":"PHASE4","title":"Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients","status":"WITHDRAWN","sponsor":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","startDate":"2010-02","conditions":"End-Stage Renal Disease","enrollment":""},{"nctId":"NCT03405974","phase":"PHASE3","title":"Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2017-10-12","conditions":"Osteonecrosis of Femoral Head, Osteonecrosis; Aseptic, Idiopathic","enrollment":114},{"nctId":"NCT01429272","phase":"PHASE3","title":"Minocycline and Aspirin in the Treatment of Bipolar Depression","status":"COMPLETED","sponsor":"Laureate Institute for Brain Research, Inc.","startDate":"2011-09","conditions":"Bipolar Disorder Depression","enrollment":99},{"nctId":"NCT03188471","phase":"PHASE4","title":"Preventive Application of GnRH Antagonist on Early OHSS","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2017-01","conditions":"Ovarian Hyperstimulation Syndrome, GnRH Antagonist, Aspirin","enrollment":175},{"nctId":"NCT02155985","phase":"PHASE2","title":"Modulation of Immune Activation by Aspirin","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2014-08","conditions":"HIV-1 Infection","enrollment":121},{"nctId":"NCT00684203","phase":"PHASE2","title":"Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-12-01","conditions":"Atherosclerosis, Myocardial Ischemia, Myocardial Infarction","enrollment":120},{"nctId":"NCT03072082","phase":"PHASE4","title":"Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization","status":"UNKNOWN","sponsor":"Jun Li","startDate":"2017-06","conditions":"Coronary Artery Disease(CAD)","enrollment":440},{"nctId":"NCT03078257","phase":"PHASE1","title":"Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2016-01-01","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT01741922","phase":"PHASE3","title":"Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients","status":"COMPLETED","sponsor":"Basque Health Service","startDate":"2012-12","conditions":"Hypertension","enrollment":230},{"nctId":"NCT00405756","phase":"PHASE3","title":"A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.","status":"COMPLETED","sponsor":"Celgene Corporation","startDate":"2007-01","conditions":"Newly Diagnosed Multiple Myeloma","enrollment":459},{"nctId":"NCT02975076","phase":"NA","title":"Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2016-12","conditions":"Stroke, Acute, Ischemic Attack, Transient","enrollment":120},{"nctId":"NCT02895113","phase":"PHASE3","title":"Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2017-01","conditions":"Diabetes","enrollment":418},{"nctId":"NCT01082874","phase":"PHASE3","title":"PeriOperative ISchemic Evaluation-2 Trial","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2010-07","conditions":"Cardiovascular Disease","enrollment":10010},{"nctId":"NCT02607072","phase":"PHASE3","title":"Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial","status":"UNKNOWN","sponsor":"The Fourth Affiliated Hospital of Anhui Medical University","startDate":"2015-10","conditions":"Colorectal Cancer","enrollment":3000},{"nctId":"NCT01675115","phase":"PHASE3","title":"Efficacy of BNG-1 to Treat Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2012-08","conditions":"Ischemic Stroke","enrollment":129},{"nctId":"NCT00249873","phase":"PHASE3","title":"Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2003-06","conditions":"Atrial Fibrillation, Vascular Risk","enrollment":7554},{"nctId":"NCT00940784","phase":"PHASE2","title":"Clopidogrel and Aspirin for the Treatment of Polycythemia Vera","status":"WITHDRAWN","sponsor":"Ronald Hoffman","startDate":"2009-06","conditions":"Polycythemia Vera","enrollment":""},{"nctId":"NCT02221102","phase":"PHASE2, PHASE3","title":"Edoxaban for TIA and Acute Minor Stroke","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2013-12","conditions":"Ischemia, Stroke, Cerebral Infarction","enrollment":3700},{"nctId":"NCT02055131","phase":"PHASE4","title":"Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis","status":"UNKNOWN","sponsor":"Tunis University","startDate":"2013-11","conditions":"Thrombosis","enrollment":300},{"nctId":"NCT01923818","phase":"PHASE2, PHASE3","title":"Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2013-09","conditions":"Ischemic Stroke, TIA","enrollment":3700},{"nctId":"NCT01890005","phase":"PHASE3","title":"Low Dose Aspirin for the Prevention of Preeclampsia","status":"UNKNOWN","sponsor":"Saint Thomas Hospital, Panama","startDate":"2013-07","conditions":"Preeclampsia","enrollment":476},{"nctId":"NCT01250340","phase":"PHASE4","title":"Type 2 Diabetes Mellitus and Atherosclerosis","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2010-08","conditions":"Type 2 Diabetes Mellitus","enrollment":80},{"nctId":"NCT01256775","phase":"PHASE2","title":"Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)","status":"COMPLETED","sponsor":"NicOx Research Institute S.r.l.","startDate":"2003-09","conditions":"Intermittent Claudication","enrollment":442},{"nctId":"NCT00385944","phase":"PHASE2","title":"The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-03","conditions":"Acute Coronary Syndrome","enrollment":56},{"nctId":"NCT00938522","phase":"PHASE4","title":"Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2009-07","conditions":"Angioplasty, Transluminal, Percutaneous Coronary","enrollment":400},{"nctId":"NCT00449618","phase":"PHASE4","title":"Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension","status":"TERMINATED","sponsor":"University of Vigo","startDate":"2007-01","conditions":"High-Normal Blood Pressure, Mild Essential Hypertension","enrollment":23},{"nctId":"NCT00536068","phase":"NA","title":"Platelet Inhibition by Aspirin, Acetaminophen and NSAID","status":"COMPLETED","sponsor":"Kantonsspital Graubünden","startDate":"2006-08","conditions":"Hemostasis","enrollment":11}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":147,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo100"],"phase":"phase_3","status":"active","brandName":"Placebo 100 (for Aspirin 100)","genericName":"Placebo 100 (for Aspirin 100)","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control formulation used in clinical trials to compare against Aspirin 100 mg. Used for Control arm in clinical trials comparing Aspirin 100 mg efficacy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}